Adaptive Biotechnologies
(NASDAQ) ADPT
Adaptive Biotechnologies Financials at a Glance
Market Cap
$2.21B
Revenue (TTM)
$295.41M
Net Income (TTM)
$49.68M
EPS (TTM)
$-0.33
P/E Ratio
-42.18
Dividend
$0.00
Beta (Volatility)
2.01 (High)
Dividend
$0.00
Beta (Volatility)
2.01 (High)
Price
$13.52
Volume
1,505,374
Open
$13.91
Price
$13.52
Volume
1,505,374
Open
$13.91
Previous Close
$13.54
Daily Range
$13.43 - $14.10
52-Week Range
$8.50 - $20.76
Dividend
$0.00
Beta (Volatility)
2.01 (High)
Price
$13.52
Volume
1,505,374
Open
$13.91
Previous Close
$13.54
Daily Range
$13.43 - $14.10
52-Week Range
$8.50 - $20.76
ADPT News
ADPT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Adaptive Biotechnologies
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
624
CEO
Chad Robins, MBA
Website
www.adaptivebiotech.comHeadquarters
Seattle, WA 98109, US
ADPT Financials
Key Financial Metrics (TTM)
Gross Margin
75%
Operating Margin
-16%
Net Income Margin
-17%
Return on Equity
-24%
Return on Capital
-11%
Return on Assets
-10%
Earnings Yield
-2.37%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.21B
Shares Outstanding
160.04M
Volume
1.51M
Avg. Volume
1.93M
Financials (TTM)
Gross Profit
$205.62M
Operating Income
$57.12M
EBITDA
$29.85M
Operating Cash Flow
$45.99M
Capital Expenditure
$2.96M
Free Cash Flow
$48.95M
Cash & ST Invst.
$226.98M
Total Debt
$280.58M
Adaptive Biotechnologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$70.87M
+35.1%
Gross Profit
$52.17M
+47.1%
Gross Margin
73.60%
N/A
Market Cap
$2.21B
N/A
Market Cap/Employee
$3.57M
N/A
Employees
619
N/A
Net Income
$20.03M
+32.9%
EBITDA
$14.38M
+51.4%
Quarterly Fundamentals
Net Cash
$10.15M
-90.5%
Accounts Receivable
$48.31M
+10.9%
Inventory
$11.21M
+29.0%
Long Term Debt
$193.86M
+153.6%
Short Term Debt
$14.32M
+36.8%
Return on Assets
-9.82%
N/A
Return on Invested Capital
-11.15%
N/A
Free Cash Flow
$10.33M
+65.3%
Operating Cash Flow
$9.54M
+66.5%